Slovakia’s association of research-based pharmaceutical companies (SAFS) has elected a new board.
Dr Pavol Trnovec
of GlaxoSmithKline, who was previously its vice-chairman, will lead SAFS as chairman. He replaces
Dr Miroslav Lednar
of ...
The US FDA recognises emerging and pandemic threats – and it aims to boost the development of cell-based viral vaccines with the publication of a final guidance entitled Guidance for Industry: Characterization and Qualification of Cell Substrates ...
Lilly expects its Japanese business to grow by double digits this year and has assured that it is on track to virtually double its sales in the country to more than $2 billion in 2014.
"We have full confidence that we will meet our targets, which ...
GlaxoSmithKline, which has yet to decide on whether or not to participate in UNITAID 's AIDS medicines patent pool, sees more value in its own licensing approach for HIV/AIDS drugs at present.
GSK chief executive
Andrew Witty
, who was in India to ...
Ark Therapeutics has withdrawn the EU filing of its brain cancer gene therapy candidate Cerepro (sitimagene ceradenovec), dropping a previous appeal over a negative opinion from the CHMP. It has at the same time initiated a full strategic review of ...
